Prolactin is released from the anterior pituitary gland which is mainly under hypothalamic inhibitory control exerted through the release of dopamine by certain neurons. Cabergoline acts as a D2 dopamine receptor agonist that mimics the effects of dopamine and leads to inhibition of prolactin release from the anterior pituitary gland.
